DE69015411D1 - 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS. - Google Patents

5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS.

Info

Publication number
DE69015411D1
DE69015411D1 DE69015411T DE69015411T DE69015411D1 DE 69015411 D1 DE69015411 D1 DE 69015411D1 DE 69015411 T DE69015411 T DE 69015411T DE 69015411 T DE69015411 T DE 69015411T DE 69015411 D1 DE69015411 D1 DE 69015411D1
Authority
DE
Germany
Prior art keywords
benzodiazepin
pyrido
dihydro
aids
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69015411T
Other languages
English (en)
Other versions
DE69015411T2 (de
Inventor
Karl D Dr Hargrave
Guenther Dr Schmidt
Wolfhard Dr Engel
Volkhard Dr Austel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BOEHRINGER INGELHEIM PHARMACEUTICALS Inc RIDGEFIELD CONN US
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
BOEHRINGER INGELHEIM PHARMACEUTICALS Inc RIDGEFIELD CONN US
Dr Karl Thomae GmbH
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOEHRINGER INGELHEIM PHARMACEUTICALS Inc RIDGEFIELD CONN US, Dr Karl Thomae GmbH, Boehringer Ingelheim Pharmaceuticals Inc filed Critical BOEHRINGER INGELHEIM PHARMACEUTICALS Inc RIDGEFIELD CONN US
Publication of DE69015411D1 publication Critical patent/DE69015411D1/de
Application granted granted Critical
Publication of DE69015411T2 publication Critical patent/DE69015411T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69015411T 1989-04-20 1990-04-12 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS. Expired - Fee Related DE69015411T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34093789A 1989-04-20 1989-04-20
US37272889A 1989-06-28 1989-06-28
US43892289A 1989-11-17 1989-11-17

Publications (2)

Publication Number Publication Date
DE69015411D1 true DE69015411D1 (de) 1995-02-09
DE69015411T2 DE69015411T2 (de) 1995-05-24

Family

ID=27407433

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69015411T Expired - Fee Related DE69015411T2 (de) 1989-04-20 1990-04-12 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS.

Country Status (8)

Country Link
EP (1) EP0393530B1 (de)
JP (1) JP2911956B2 (de)
AT (1) ATE116320T1 (de)
CA (1) CA2014884C (de)
DE (1) DE69015411T2 (de)
DK (1) DK0393530T3 (de)
ES (1) ES2066897T3 (de)
GR (1) GR3015469T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0475231A1 (de) * 1990-09-10 1992-03-18 F. Hoffmann-La Roche Ag Benzodiazepine
GB9109557D0 (en) * 1991-05-02 1991-06-26 Wellcome Found Chemical compounds
AU5883794A (en) * 1993-01-20 1994-08-15 A. Menarini Industrie Farmaceutiche Riunite S.R.L. Diazepin derivatives and antiviral compositions
US6593337B1 (en) 1999-10-19 2003-07-15 Bristol-Myers Squibb Pharma Company Tricyclic compounds useful as HIV reverse transcriptase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1542160A (fr) * 1966-10-31 1968-10-11 Thomae Gmbh Dr K Procédé de fabrication de nouvelles 5, 11-dihydro-6h-pyrido-[2, 3-b] [1, 4]-benzodiazépine-6-ones substituées en position 11

Also Published As

Publication number Publication date
GR3015469T3 (en) 1995-06-30
JP2911956B2 (ja) 1999-06-28
EP0393530B1 (de) 1994-12-28
ES2066897T3 (es) 1995-03-16
DK0393530T3 (da) 1995-05-22
JPH0363275A (ja) 1991-03-19
ATE116320T1 (de) 1995-01-15
DE69015411T2 (de) 1995-05-24
CA2014884A1 (en) 1990-10-20
EP0393530A1 (de) 1990-10-24
CA2014884C (en) 1999-09-07

Similar Documents

Publication Publication Date Title
NO990542D0 (no) K-252a-derivater og anvendelse av K-252a-derivater
DE19975051I2 (de) 5,11-Dihydro-6H-dipyrido(3,2-b:2'3'-e)(1,4)diazepine und ihre Verwendung zur Verhinderung oder Behandlung von HIV-Infektionen.
DE69626915D1 (de) 8-Arylalkyl- und 8-Arylheteroalkyl-5, 11-dihydro-6H-dipyrido-(3,2-b:2', 3'-e)(1,4)diazepine und ihre Verwendung zur Vorbeugung oder Behandlung von HIV-Infektion
ATE103918T1 (de) 5,11-dihydro-6h-dipyrido(3,2-b:2',3'e>(1,4>diazepin-6-one und -thione und ihre verwendung bei der aids-vorbeugung oder behandlung.
DE68925004D1 (de) Verwendung von 2,3,4,5-Tetrahydro-1H-3-Benzazepinen bei der Behandlung von neurologischen Störungen.
DE69002079D1 (de) 5,11-dihydro-6h-dipyrido (3,2-b:2',3'-e)diazepin-6-one und deren verwendung in der vorbeugung und behandlung von aids.
FI945000A (fi) Menetelmä (S)-amino-1-substituoitujen pyrrolidiinien valmistamiseksi
CA2014885A1 (en) 6,11-dihydro-5h-pyrido[2,3-b][1,5]benzodiazepin-5-ones and thiones and their use in the prevention or treatment of aids
DE69015411T2 (de) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS.
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
ES2044100T4 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
MY105555A (en) Heterocyclicguanidines as 5ht 3 antagonists.
DE3751362D1 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.
DE69213777D1 (de) Pyridobenzodiazepine, Dipyrido-[3,2-b:2',3'-3] [1,4]-diazepine und deren Verwendung in der Vorbeugung und Behandlung von AIDS
ES2129053T3 (es) Nuevos derivados de fosfolipidos.
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
ATE137239T1 (de) Thienopyrazin-2,3-dione verwendbar bei der behandlung von zns-störungen, und ihre herstellung.
EP0412941A3 (en) Phospholipids for the treatment of multiple sclerosis
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물
SU1602007A1 (ru) 6-(4,5-Дифенилтиенил-2)-3-тиа-1,2,4-триазин-5-он, проявляющий противовоспалительную и антимикробную активность

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee